Ethyl 2-(4-bromo-5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl)acetate

Catalog No. :
ACNXMV087
CAS No. :
1002033-75-1
Molecular Formula :
C11H13BrF2N2O2
Molecular Weight :
323.14

IUPAC Name:ethyl 2-(4-bromo-5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl)acetate

Ethyl 2-(4-bromo-5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$242.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(4-bromo-5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl)acetate
IUPAC Nameethyl 2-(4-bromo-5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl)acetate
MDL No.MFCD04967337
Molecular FormulaC11H13BrF2N2O2
Molecular Weight323.14
SMILESO=C(OCC)CN1N=C(C(F)F)C(Br)=C1C2CC2
InChI KeyLNGLAGJIIXCQDW-UHFFFAOYSA-N
Synonymethyl [4-bromo-5-cyclopropyl-3-(difluoromethyl)-1H-pyrazol-1-yl]acetate;Ethyl 2-(4-bromo-5-cyclopropyl-3-(difluoromethyl)-1h-pyrazol-1-yl)acetate;1H-Pyrazole-1-acetic acid, 4-bromo-5-cyclopropyl-3-(difluoromethyl)-, ethyl ester
CAS No.1002033-75-1

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNXMV087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNXMV087 route product structure diagram
    ACNXMV0871002033-75-1
Inquiry

2. ACNXMV087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNXMV087 route product structure diagram
    ACNXMV0871002033-75-1
Inquiry

Comments (0)